Product Pipeline
Treatment candidate |
Indication |
Clinical Trial Status |
|---|---|---|
TVI-Brain-1 |
Grade 4 astrocytoma |
Planned pivotal Phase III with initiation of enrollment expected following completion of the offering |
Grade 4 glioma |
Phase II ongoing |
|
TVI-Kidney-1 |
Stage 4 renal cell carcinoma |
Phase III ready |